Mediktor, a Barcelona, Spain-based symptom checker for pre-diagnosis, triage and decision-making support, raised $3.4m in Series A funding.
The round was led by Alta Life Sciences Spain I FCR, with participation from Castel Capital, Naos, as well as other minority partners.
The company intends to use the funds to advance the commercialization of its Artificial Intelligence application in the North American market, to reinforce and improve the platform both technically and scientifically.
Founded in 2011 by Oscar García-Esquirol, doctor specialist in intensive care medicine and Cristian Pascual, industrial engineer & MBA, Mediktor is a clinically-validated symptom checker for pre-diagnosis, triage and decision-making support. The technology combines artificial intelligence, natural language recognition and patient data to detect symptoms and offer a listing of possible conditions, treatment recommendations and a connection with medical professionals within a health insurance network.
The platform learns from every interaction, developing an advanced intuition. Mediktor has already performed 2 million symptom evaluations in more than 200 countries globally developing an intuition comparable to a full life experience of 10 physicians.
The company, which has an office in New York, is partnering with major insurance companies and main referral hospitals across the world, including Münich RE Group, an international reinsurance company, represented in over 30 countries and concentrated on Europe and Asia.